Cargando…
Noninvasive Urine Biomarker Lateral Flow Immunoassay for Monitoring Active Onchocerciasis
[Image: see text] The parasitic disease onchocerciasis is the second leading cause of preventable blindness, afflicting more than 18 million people worldwide. Despite an available treatment, ivermectin, and control efforts by the World Health Organization, onchocerciasis remains a burden in many reg...
Autores principales: | Shirey, Ryan J., Globisch, Daniel, Eubanks, Lisa M., Hixon, Mark S., Janda, Kim D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189908/ https://www.ncbi.nlm.nih.gov/pubmed/30141624 http://dx.doi.org/10.1021/acsinfecdis.8b00163 |
Ejemplares similares
-
Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG)
por: Globisch, Daniel, et al.
Publicado: (2017) -
Metabolomics-Based Discovery of Diagnostic Biomarkers for Onchocerciasis
por: Denery, Judith R., et al.
Publicado: (2010) -
Magnetic Lateral Flow Immunoassays
por: Moyano, Amanda, et al.
Publicado: (2020) -
Market Trends in Lateral Flow Immunoassays
por: Rosen, Shara
Publicado: (2008) -
What is the Role of Lateral Flow Immunoassay for the Diagnosis of Melioidosis?
por: Currie, Bart J, et al.
Publicado: (2022)